Tuhura Biosciences Inc (HURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,682 | -15,687 | -10,107 | -4,842 | -3,985 |
| Depreciation Amortization | 1,395 | 1,206 | 508 | 52 | 30 |
| Other Working Capital | 3,287 | 1,159 | -246 | 634 | 98 |
| Other Operating Activity | 2,273 | 1,193 | 945 | 323 | 423 |
| Operating Cash Flow | $-14,728 | $-12,129 | $-8,900 | $-3,834 | $-3,434 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -58 | -5,229 | -37 | N/A | -20 |
| Net Acquisitions | -5,995 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-6,052 | $-5,229 | $-37 | $0 | $-20 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 28,568 | 28,568 | 19,068 | 4,903 | N/A |
| Common Stock Issued | 7,049 | 7,035 | N/A | 0 | 2,581 |
| Dividend Paid | N/A | N/A | N/A | N/A | -4 |
| Other Financing Activity | -5,844 | -2,315 | -1,485 | -272 | 0 |
| Financing Cash Flow | $29,773 | $33,288 | $17,583 | $4,631 | $2,577 |
| Beginning Cash Position | 3,665 | 3,665 | 3,665 | 3,665 | 1,535 |
| End Cash Position | 12,657 | 19,596 | 12,311 | 4,462 | 658 |
| Net Cash Flow | $8,992 | $15,931 | $8,646 | $797 | $-877 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,728 | -12,129 | -8,900 | -3,834 | -3,434 |
| Capital Expenditure | -58 | -5,229 | -37 | 0 | -20 |
| Free Cash Flow | -14,786 | -17,357 | -8,937 | -3,834 | -3,454 |